Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Revenue: 2018-2024

Historic Revenue for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Dec 2024 value amounting to $152.3 million.

  • Arcturus Therapeutics Holdings' Revenue fell 58.84% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.6 million, marking a year-over-year decrease of 39.15%. This contributed to the annual value of $152.3 million for FY2024, which is 8.69% down from last year.
  • As of FY2024, Arcturus Therapeutics Holdings' Revenue stood at $152.3 million, which was down 8.69% from $166.8 million recorded in FY2023.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Revenue peaked at $206.0 million during FY2022, and registered a low of $9.5 million during FY2020.
  • For the 3-year period, Arcturus Therapeutics Holdings' Revenue averaged around $175.0 million, with its median value being $166.8 million (2023).
  • Its Revenue has fluctuated over the past 5 years, first slumped by 54.12% in 2020, then surged by 1,566.79% in 2022.
  • Yearly analysis of 5 years shows Arcturus Therapeutics Holdings' Revenue stood at $9.5 million in 2020, then rose by 29.56% to $12.4 million in 2021, then soared by 1,566.79% to $206.0 million in 2022, then dropped by 19.03% to $166.8 million in 2023, then dropped by 8.69% to $152.3 million in 2024.